Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-001571
Filing Date
2022-01-11
Accepted
2022-01-11 15:35:24
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4108
  Complete submission text file 0000899243-22-001571.txt   5471
Mailing Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201
Business Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 (254) 244-5739
Vaxxinity, Inc. (Issuer) CIK: 0001851657 (see all company filings)

EIN.: 862083865 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VAXXINITY, INC. 1717 MAIN ST. STE.3388 DALLAS TX 75201
Business Address
Pesile Jason (Reporting) CIK: 0001903670 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41058 | Film No.: 22523785